Global Medicines Program

Publications

Improving safety, quality and efficacy of medicines in the Americas. Bolaños et al. Rev Panam Salud Publica 39(5), 2016. Access publication.

Development of a pharmacovigilance safety monitoring tool for the rollout of single low‑dose primaquine  and artemether‑lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study. Poirot et al. Malar J (2016) 15:384. Access publication.

Examination of patient flow in a rural health center in Malawi. Jafry MA, Jenny AM, Lubinga SJ, Larsen‑Cooper E, Crawford J, Matemba C and Babigumira JB. BMC Res Notes (2016) 9:363. Access publication.

Health technology assessment in low- and middle-income countries: a landscape assessment. Babigumira JB, Jenny AM, Bartlein R, Stergachis A, and Garrison LP. JPHS 2015. DOI 10.1111/jphs.12120 Access publication.

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Tinto H, et al. Reproductive Health(2015) 12:112. Access publication.

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya. Dellicour S, et al. Malar J (2015) 14:461. Access publication.

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda. Lubinga SJ, Atukunda EC, Wasswa-Ssalongo G, Babigumira JB. 2015. PLoS ONE 10(11): e0142550. Access publication.

A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda. Lubinga SJ, Mutamba BB, Nganizi A, Babigumira JB. Applied Health Economics and Health Policy May 2015. Access publication.

Treating severe malaria in pregnancy: a review of the evidence. Drug Safety. Kovacs SD, Rijken M, Stergachis A. Jan 4, 2015. DOI 10.1007/s40264-014-0261-9. Full Text.

Pharmaceutical Availability across Levels of Care: Evidence from Facility Surveys in Ghana, Kenya, and Uganda. Masters SH, Burstein R, DeCenso B, Moore K, Haakenstad A, Ikilezi G, Achan J, Osei I, Garshong B, Kisia C, Njuguna P, Babigumira J, Kumar S, Hanlon M, Gakidou E. PLoS One. 2014 Dec 11;9(12):e114762. Full Text.

Actions of the national regulatory authorities in 10 low- and middle-income countries following stringent regulatory authority safety alerts on rosiglitazone. Nwokike J, Kabore L, Stergachis A. Therapeutic Innovation & Regulatory Science. 3 October 2014. Full Text.

Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunities. Agapova M, Devine EB, Bresnahan BW, Higashi MK, Garrison LP. Acad Radiol. 2014 Sep;21(9):1138-43. Abstract.

Impact of pharmacy worker training and deployment on access to essential medicines and health outcomes in Malawi: protocol for a cluster quasi-experimental evaluation. Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A, and Babigumira JB. Implementation Science 2014, 9:156 Full Text.

Pharmacy and HIV testing: A good start…finally. Andy Stergachis. J Am Pharm Assoc 2014;54:476 Full Text.

Enhancing Health Outcomes for Chronic Diseases in Resource-Limited Settings by Improving the Use of Medicines: The Role of Pharmaceutical Care. Submitted to USAID by the SIAPS Program. June 2014.  Full Report.

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries. Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L, Stergachis A. PLoS ONE 2014, 9(3): e90601. doi:10.1371/journal.pone.0090601. Full Text.

A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries. Babigumira JBB, Stergachis A, Choi HL, Dodoo A, Nwokike J, Garrison LP. Drug Saf DOI 2014, 10.1007/s40264-014-0143-1. Full Text.

The Association between Malaria and Iron Status or Supplementation in Pregnancy: A Systematic Review and Meta-Analysis. Sangare L, van Eijk AM, ter Kuile FO, Walson J, Stergachis A. PLoS ONE 2014, 9(2): e87743. Full Text.

Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance. Roth GA, Gillespie CW, Mokdad AA, Shen DD, Fleming DW, Stergachis A, Murray CJL, Mokdad AH. BMC Cardiovascular Disorders 2014, 14:16. Full Text.

Health-related quality of life and social support among women treated for abortion complications in western Uganda. Lubinga SJ, Levine GA, Jenny AM, Ngonzi J, Mukasa-Kivunike P, Stergachis A, Babigumira JB.  Health Qual Life Outcomes. 2013 Jul 15;11(1):118.  Abstract.

Probabilistic record linkage for monitoring the safety of artemisinin based combination therapy in the first trimester of pregnancy in Senegal.  Dellicour S, Brasseur P, Thorn P, Gaye O, Olliaro P, Badiane M, Stergachis A, ter Kuile FO.   Drug Safety.   DOI 10.1007/s40264-013-0059-1.  Abstract.

Health economics of rubella: a systematic review to assess the value of rubella vaccination.  Babigumira JB, Morgan I, Levin A.  BMC Public Health. 2013 Apr 29;13:406. doi: 10.1186/1471-2458-13-406.  Abstract   or Full Text

Prescribers’ Need for and Access to Drug Information Resources in Ethiopia. Hussien N, Musa S, Stergachis A, Wabe NT, Suleman S. Therapeutic Innovation & Regulatory Science. Published online 7 January 2013. doi: 10.1177/2168479012460758. Abstract or Full text

Determinants of Use of Insecticide Treated Nets for the Prevention of Malaria in Pregnancy: Jinja, Uganda. Sangare´LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A. PLoS ONE June 2012; 7 (6) e39712.  Full text

Pharmacovigilance and global HIV/AIDS. Miller V, Nwokike J, Stergachis A. Curr Opin HIV AIDS. 2012 Jul;7(4):299-304. Abstract

Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda. Babigumira JB, Stergachis A, Veenstra DL, Gardner JS, Ngonzi J, Mukasa-Kivunike P, Garrison LP. 2012 Feb 17. PLoS ONE 7(2): e30735. doi:10.1371/journal.pone.0030735. Full text

An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A. BMC Health Serv Res. 2012 Feb 2;12(1):30. [Epub ahead of print]. Full text

Estimating the Costs of Induced Abortion in Uganda: A Model-Based Analysis. Babigumira J, Stergachis A, Veenstra DL, Gardner JS, Ngonzi J, Mukasa-Kivunike P, Garrison LP. BMC Public Health 2011, 11:904 doi:10.1186/1471-2458-11-904. Full text

Pilot evaluation of the psychometric properties of a self-medication Risk Assessment Tool among elderly patients in a community setting. Lubinga S, Millar I, Babigumira J. BMC Research Notes 2011, 4:398 doi:10.1186/1756-0500-4-398. Full text

Records linkage of electronic databases for the assessment of adverse effects of antiretroviral therapy in sub-Saharan Africa. Corbell C, Katjitea I, Mengistu A, Kalemeera F, Sagwa E, Mabirizi D, Lates J, Nwokike J, Fuller S, Stergachis A. Pharmacoepidemiology and Drug Safety. Published online 18 October 2011. doi: 10.1002/pds.2252. Full text

Assessing vaccine safety communication with healthcare providers in a large urban county. Meranus D, Stergachis A, Arnold J, Duchin J. Pharmacoepidemiology and Drug Safety. Published online 28 Sep 2011. doi: 10.1002/pds.2245. Full text

Strengthening Pharmaceutical Care Education in Ethiopia Through Instructional Collaboration. Odegard PS, Tadeg H, Downing D, Suleman S, Bedada W, Paulos G, Mekonnen H,  Negussu M, Bartlein R, Stergachis A. American Journal of Pharmaceutical Education. 2011: Volume 75, Issue 7, Article 134. doi: 10.5688/ajpe757134. Full text

Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. Bakare N, Edwards IR, Stergachis A, Pal S, Holmes CB, Lindquist M, Duncombe C, Dodoo A, Novendstern J, Nwokike J, Kuchenbecker R, Aberg JA, Miller V, Strobos J. PLoS Med. 2011 July; 8(7): e1001054. Published online 2011 July 5.  doi:  10.1371/journal.pmed.1001054. Full text

Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program. Babigumira JB, Levin A, Burgess C, Garrison LP, Bauch CT, Braka F, Mbabazi W, Nabyonga JO, Simons E, and Dabbagh A. J Infect Dis. 2011. 204 (suppl 1):S116-S123.doi: 10.1093/infdis/jir132. Full text

Using Cost-Effectiveness Analysis to Support Research and Development Portfolio for Product Innovations in Measles Vaccination. Garrison LP, Bauch CT, Bresnahan BW, Hazlet TK, Kadiyala S, Veenstra DL. J Infect Dis. 2011. 204 (suppl 1): S124-S132. doi: 10.1093/infdis/jir114. Full text

Global Eradication of Measles: An Epidemiologic and Economic Evaluation. Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, Dabbagh A. J Infect Dis. 2011. 204 (suppl 1): S98-S106. doi: 10.1093/infdis/jir096. Full text

Patterns of anti-malarial drug treatment among pregnant women in Uganda. Sangaré LR, Weiss NS, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Stergachis A. Malaria Journal. 2011 10:152. Full text

Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda. Babigumira JB, Castelnuovo B, Stergachis A, Kiragga A, Shaefer P, Lamorde M, Kambugu A, Muwanga A, Garrison LP.  PLoS One. 2011 Mar 28;6(3):e18193. Full text

Patient Volume, Human Resource Levels and Attrition from HIV Treatment Programs in Central Mozambique. Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A.  J Acquir Immune Defic Syndr. 2011 Mar 3. Abstract

Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. Sangaré L, Stergachis A, Brentlinger PE, Richardson BA, Staedke SG, Kiwuwa MS, Weiss NS.  PLoS One. 2010 Nov 29;5(11):e15066. Full text

An analysis of pharmacovigilance activities in 55 low- and middle income countries. Olsen S, Pal S, Stergachis A, Couper M. Drug Safety.  2010;33:689-703. Abstract

A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S Presidents’ Malaria Initiative proposals. Stergachis A, Bartlein R, Dodoo A, Nwokike J, Kachur SP.  Malaria J.  2010: 9:148. Full text

Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria Endemic Countries. Dellicour S, ter Kuile F, Stergachis A.  PLoS Medicine. 2010. Vol. 5, No. 9, e187 doi:10.1371/journal.pmed.0050187. Full text

Genital Ulcer Disease Treatment Policies and Access to  Acyclovir in Eight Sub-Saharan African Countries. Corbell C, Stergachis A, Ndowa F, Barnes L, Ndase P, Barnes L, Celum C.  Sexually Transmitted Diseases. August 2010; Vol. 37; Issue 8:488-493. doi: 10.1097/OLQ.0b013e3181e212e5. Abstract

A review of data needed to parameterize a dynamic model of measles in developing countries. Szusz EK, Garrison LP, Bauch CT.  BMC ResNotes. 2010 Mar 16;3:75.  Full text

Economic Evaluation of Task Shifting in Follow-up of Patients on Antiretroviral Therapy in a Resource-Limited Setting. Babigumira J, Castelnuovo B, Lamorde M, Kambugu A, Stergachis A, Easterbrook P, Louis P. Garrison G. BMC Health Services Research 2009, 9:192. doi:10.1186/1472-6963-9-192. Full text

Supporting Pharmacovigilance in Developing Countries. Contributing Authors: Stergachis A, Wawaru C.  Strengthening Pharmaceutical Systems (SPS).  USAID, Arlington, VA: Management Sciences for Health, 2009. Full text

Strengthening Pharmaceutical Systems (SPS) Program: Indicator-Based Pharmacovigilance Assessment Tool: Manual for Conducting Assessments in Developing Countries. Contributing Author:  Stergachis.  Submitted to the U.S. Agency for International Development by the SPS Program. Arlington, VA: Management Sciences for Health, 2009. Full text

Scheduling of measles vaccination in low-income countries: projections of a dynamic model. Bauch CT, Szusz E, Garrison LP. Vaccine. 2009 Jun 24;27(31):4090-8. Epub 2009 May 14. Full text